Alembic Pharma JV Aleor Dermaceuticals gets USFDA EIR for Karakhadi facility
Advertisement
Gujrat: Aleor Dermaceuticals Ltd has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Formulation Facility at Karakhadi, Gujarat, India.
USFDA had inspected the Karakhadi facility from 6 th January 2020 to 8th January 2020.
Aleor Dermaceuticals Ltd. is a 60:40 Joint Venture between Alembic Pharmaceuticals Ltd. and Orbicular Pharmaceutical Technologies Pvt. Ltd.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.